- Report
- June 2021
- 203 Pages
Global
From €3026EUR$3,185USD£2,603GBP
€4323EUR$4,550USD£3,718GBP
- Report
- July 2021
- 136 Pages
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- July 2021
- 143 Pages
North America
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- July 2021
- 143 Pages
Middle East, Africa
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- July 2021
- 156 Pages
Europe
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- July 2021
- 154 Pages
Asia Pacific
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- October 2021
- 100 Pages
Global
From €4275EUR$4,500USD£3,678GBP
- Report
- April 2023
- 110 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- June 2018
- 124 Pages
Global
From €10446EUR$10,995USD£8,986GBP
- Report
- December 2020
- 97 Pages
Middle East, Africa
From €1425EUR$1,500USD£1,226GBP
- Report
- December 2020
- 205 Pages
Global
From €3420EUR$3,600USD£2,942GBP
- Drug Pipelines
- November 2020
- 65 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Report
- July 2022
- 80 Pages
Africa
From €3605EUR$3,795USD£3,101GBP
- Report
- July 2022
- 40 Pages
Saudi Arabia
From €2465EUR$2,595USD£2,121GBP
- Report
- July 2022
- 40 Pages
India
From €2465EUR$2,595USD£2,121GBP
- Report
- September 2020
- 88 Pages
Global
From €3800EUR$4,000USD£3,269GBP
- Report
- December 2018
- 95 Pages
Global
From €3325EUR$3,500USD£2,860GBP
- Report
- April 2023
- 96 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- July 2022
- 40 Pages
Argentina
From €2465EUR$2,595USD£2,121GBP
- Report
- July 2022
- 40 Pages
Poland
From €2465EUR$2,595USD£2,121GBP
The Epipen is a brand of epinephrine auto-injector used to treat severe allergic reactions, such as anaphylaxis. It is a device that delivers a single dose of epinephrine, a hormone that helps to reduce the symptoms of an allergic reaction. The Epipen is the most widely used epinephrine auto-injector on the market and is available in both adult and pediatric doses. It is used by people with severe allergies to help prevent anaphylaxis, a potentially life-threatening allergic reaction.
The Epipen is part of the larger allergy drug market, which includes a variety of medications and treatments used to treat allergies. These include antihistamines, decongestants, corticosteroids, and immunotherapy. Allergy drugs are used to treat a wide range of allergic reactions, from mild to severe.
The Epipen market is highly competitive, with several companies offering their own versions of the device. These include Mylan, Sanofi, Impax Laboratories, and Teva Pharmaceuticals. Other companies, such as Kaleo and Adamis Pharmaceuticals, have also developed their own epinephrine auto-injectors. Show Less Read more